Cavinton

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2018
0102019762018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
The study was conducted in 3 Russian centers (Moscow, St. Petersburg and Nizhniy Novgorod). The total sample included 110… (More)
Is this relevant?
2003
2003
According to pharmacological studies, cavinton has an effect on the end links of aminoglycosides interaction with elements of the… (More)
Is this relevant?
1998
1998
The effects of vinpocetine (Cavinton) on the cerebral glucose metabolism of chronic stroke patients are studied with positron… (More)
Is this relevant?
1992
1992
Cavinton was used for 10 years in 967 patients with different cerebrovascular diseases. The highest effect was seen in patients… (More)
Is this relevant?
1991
1991
The authors studied the efficacy of cavinton as an agent helpful in preventing neurologic disorders in the newborn with hypoxic… (More)
Is this relevant?
1987
1987
The pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA), were studied in the aged. Vinpocetine was… (More)
  • table 1
  • figure I
  • table 2
  • figure 2
Is this relevant?
1986
1986
The authors studied the effect of cavinton (15-45 mg/day) and its combinations with different anticonvulsants on the time-course… (More)
Is this relevant?
1986
1986
Cavinton was shown to protect mice against convulsions induced by corazol, strychnine and thiosemicarbazide. In addition… (More)
Is this relevant?
1984
1984
The pharmacokinetics of vinpocetine after 10 mg po and iv doses was studied in six beagle dogs treated in cross-over design. The… (More)
Is this relevant?
1976
1976
Of a series of 100 patients 46 were given combined (i.m. and oral) treatment with ethyl apovincaminate (RGH-4405, Cavinton) in… (More)
Is this relevant?